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Any surface of human interest can serve as a substrate for biofilm growth, sometimes with 
detrimental effects. The social and economic consequences of biofilm-mediated damage to 
surfaces are significant, the financial impact being estimated to be billions of dollars every year. 
After describing traditional biocide-based approaches for the remediation of biofilm-affected 
surfaces, this review deals with more recent developments in material science, focusing on non-
toxic, eco-sustainable nature-inspired biomaterials with anti-biofilm properties superior to the 
conventional biocide-based approaches in terms of addressing the biofilm problem. 
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Introduction 
Any surface of human interest can serve as a starting ground for biofilm 
development, limiting material application and increasing health risks and costs. The 
inclination of microorganisms to become surface bound is ubiquitous, suggesting that 
surface dwellers have a strong survival and/or selective advantage tendency greater than 
their free-floating counterparts, i.e. a certain degree of shelter and homeostasis that 
helps them persist in the environment (Dunne, 2002).  
On the global scale, biofilm-related costs incur the spending of billions of 
dollars in different sectors of the economy including all clinical and industrial settings 
associated with surfaces (Plyuta et al. 2013). Most likely, the worst biofilm reputation 
belongs to biofilm associated with the medical and healthcare sectors, because they are 
responsible for more than 60% of all microbial infections in humans (Sadekuzzaman et 
al. 2015). Indeed, implantable medical devices applied to critically ill patients often 
become potential surfaces for biofilm formation, with devastating medical implications 
in terms of patient morbidity, mortality, prolonged hospitalization and increased 
healthcare costs (Hall-Stoodley et al. 2004; Darouiche 2007; Lo et al. 2014; Percival et 
al. 2015; Tenke et al. 2017).  
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The detrimental effects of biofilm can also be felt across numerous industries, 
including water treatment and distribution, food processing and marine-based industries. 
The result is a decrease in industrial productivity as well as the physical deterioration of 
industrial systems such as pipe plugging and corrosion (Stowe et al. 2011). In food-
processing environments, biofilms are of special importance as they have the potential 
to act as a persistent source of microbial contamination, which can lead to the 
threatening of the microbiological quality and safety of food products, resulting in food-
borne disease (Cappitelli et al. 2014). Approximately 95% of bacterial cells that grow in 
drinking water networks are attached to pipe walls, while less than 5% has been found 
in the water phase (Flemming 2002; Douterelo et al. 2016). Detrimental effects include 
microbe-induced corrosion, disinfectant depletion, color, odor and taste degradation and 
the microbiological deterioration of drinking water (Farkas et al. 2013).  
Biofilm also affects the surface of buildings and monuments, both historic and 
modern (Polo et al. 2012; Villa et al. 2016; Vázquez-Nion et al. 2018). As a 
consequence of complex interactions within the microbial community and its substrate 
biodeterioration processes occur (Giacomucci et al. 2011; Cappitelli et al. 2012). The 
consequences are aesthetic and structural damage. 
Historically, most strategies that attempt to mitigate the effects of biofilm focus 
on treatments aimed at killing the microbial cells in biofilm already present on solid 
surfaces. However, such strategies have limited efficacy owing to bacterial persistence 
and resistance in pre-formed biofilm (Feng et al. 2015). Indeed, sessile bacteria exploit 
features that make them up to 1,000-fold more resistant to antibiotic and biocide 
treatments than their corresponding planktonic counterparts (Stewart 2002). In vitro 
experiments have shown that young, less dense biofilm is more easily cleared away by 
antibiotic treatment than mature thicker biofilm (Stewart 2015). However, early 
diagnosis of biofilm infection is currently difficult, and most biofilm infections are 
caused by matured biofilm, thus making it difficult to eradicate them with antibiotic 
treatments (Wu et al. 2015). Additionally, biofilm treatment is hindered by the dramatic 
increase in antibiotic resistance among pathogens, reducing the possibility of treating 
infections effectively and increasing the risk of complications and a fatal outcome.  
No less important are chemical treatments that often involve considerable 
amounts of potentially dangerous substances. Sooner or later biocides and antibiotics 
are released into the environment and, if they do not break down into safer constituent 
 3 
 
parts, they persist intact over prolonged periods of time, raising severe environmental 
and human risks (Young et al. 2008; Schultz et al. 2011; Sousa et al. 2014). This is 
readily seen in the growing number of policies, directives, technical reports, strategies, 
recommendations and regulatory decisions designed to reduce the consumption of 
antimicrobial agents, ensuring their prudent use, and protect human and animal health 
and wellbeing (Directive 98/8/EC; Council Recommendation 2002/77/EC; SCENIHR 
report 2009; EFSA Summary Report 2012). 
With regard to the severe adverse impact of biofilm on many human activities, 
this review provides an overview of current and advanced strategies employed to 
control and prevent unwanted biofilm on polymeric surfaces in recent years. Materials 
and coatings with antibacterial activity, as well as more recent biofilm resistant 
solutions based on non-toxic natural molecules, including advantages and disadvantages 
with respect to potential applications, are discussed (Tables 1 and 2). Finally, methods 
for assessing anti-biofilm performance of innovative polymeric surfaces are presented. 
 
Surface modification 
The resistance of biofilm cells to traditionally used antimicrobial agents has 
prompted researchers to focus on preventive strategies rather than on attempts that 
remove or kill microorganisms. The development of materials that can resist or prevent 
bacterial adhesion constitutes the most promising and emerging approach to deal with 
material-associated biofilm infection problems (Alves and Pereira 2016). These 
approaches aim at altering the polymer surface by using passive or active strategies that 
discourage microbial adhesion and thus biofilm formation (Coenye et al. 2011).  
 
Passive surfaces 
In passive strategies, the physiochemical properties of an existing material, such 
as composition, charge, hydrophobicity, roughness and porosity, are modified so as to 
minimize microbial adhesion upon contact, without releasing biocidal agents into the 
surrounding environment (Gbejuade et al. 2015; Romanò et al. 2015).  These coatings 
are called passive, because their effect is not attributed to antimicrobially active 
functional groups.   
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Surface chemistry modifications 
In the past, poly(-ethylene oxide) (Johnston et al. 1997; Roosjen et al. 2003; 
Roosjen et al. 2005), poly(ethylene glycol) (Holmberg et al. 1993; Park et al. 1998; 
Kingshott et al. 2003; Tedjo et al. 2007; Saldarriaga Fernández et al. 2007) and 
hydrophilic polyurethanes (Jansen et al. 1993; Nagel et al. 1996) were used extensively 
as passive coatings to increase surface protection against biofilm formation. Indeed, 
these anti-adhesive coatings reduce the adhesion force between the bacteria and the 
solid surface, enabling easy removal of bacteria before the formation of surface biofilm 
(Adhart et al. 2018).   
These strategies are relatively simple and economic ways to counteract 
microbial colonization. However, despite their popularity in the academic literature, few 
commercially marketed biomedical coatings are available, perhaps due to the difficulties 
in creating surface-bound thin films amenable at industrial scale (Sjollema et al. 2018).  
Additionally, these passive coatings have been shown to reduce the adhesion of 
bacteria and yeast in vitro, but after exposure to physiological fluids in vitro or in vivo, 
the reduction in microbial adhesion is usually small or soon lost (Roosjen et al. 2005; 
Saldarriaga Fernández et al. 2007). The anti-biofilm properties of the coating are 
quickly masked by an adsorbed conditioning film of bacteria-produced proteins that 
diminishes its effectiveness (Hetrick and Schoenfisch 2006) whereas coating 
degradation can also occur (e.g. hydrolysis, chain cleavage, surface removal) 
(Saldarriaga Fernández et al. 2007). Furthermore, surfaces that are non-adhesive to 
bacteria are often non-adhesive to tissue cells as well, making them less suitable for 
biomaterial implants and devices requiring tissue integration (Sjollema et al. 2018). 
Finally, the introduction of additional chemical species decreases biocompatibility 
(Dickson et al. 2015).  
 
Surface topography modifications 
Modification of surface topography with micro- and nanoscale features that 
minimize bacterial attachment is another passive strategy for preventing biofilm 
formation on abiotic surfaces. Indeed, surfaces with topographic features of dimensions 
much smaller than microbial cells, in the sub-micrometer or nanometer range, have 
been reported to inhibit attachment by reducing the contact area between bacteria and 
the surface (Hsu et al. 2013).  
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An interesting development in this area is the recognition that nature has 
developed numerous surfaces with highly optimized nanoscale topography able to 
minimize microbial attachment. Therefore, many studies have attempted to mimic the 
peculiar surfaces found in nature. Carman et al. (2006) developed engineered 
microscale surface design inspired by the topography of shark skin (with features 2 µm 
wide, 3 µm in height) able to disrupt biofilm formation on patterned 
poly(dimethylsiloxane) elastomer without the use of biocidal agents. Regularly spaced 
nanopillar structures, similar to those found on the bactericidal cicada wings, were 
reproduced on a black silicon surface by Ivanova et al. (2013) with optimal bactericidal 
effect against both Gram-positive and Gram-negative bacteria. A superhydrophobic and 
biocompatible micro/nano structure gecko skin-like surface with low adhesion, anti-
wetting, self-cleaning and antibacterial properties has been developed by Watson et al. 
(2015) and Li et al. (2016). Other examples of bio-inspired surfaces with effective anti-
adherence nanoscale feature include those resembling rose petals, lotus leaves, taro 
leaves, rice leaves and legs of water striders (Claudia et al. 2016; Barthlott et al. 2017). 
According to these researchers, bacterial cells are killed through the mechanical 
rupture of their cell wall when they are in contact with the nanostructures (Tripathy et 
al. 2017). Therefore, recruitment of additional cells and biofilm build up are both 
prevented and resistance to the nanofeatures cannot evolve (Dickson et al. 2015). 
Unfortunately, these discoveries have not been translated to technologically 
scalable processes yet. Indeed, most of nanostructuring methods available today require 
cleanroom technologies and are prohibitively expensive, slow and cumbersome for 
large-scale applications (Feng et al. 2015; Hasan et al. 2018). Additionally, although 
most studies have shown that biofilms are sensitive to nanoscale topographical details, 
no universal rules of attachment have been determined yet and some researchers have 
reported a greater level of attachment on some nanoscale surfaces compared to those 
with conventional topographies (Park et al. 2008; Hsu et al. 2013). 
 
Active antimicrobial surfaces 
In active approaches, the abatement of biofilm growth has been achieved by 
spreading a number of antimicrobials and disinfectants onto the surfaces or by 
incorporating them into synthetic polymer-based products, directly or by means of a 
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carrier. The anti-biofilm activity is the result of functional groups that interact with 
microbes in the surrounding area (Lichter et al. 2009). 
 
Antimicrobial-releasing surfaces       
In the antimicrobial-releasing surfaces, the biocidal agent is actively eluted from 
the surface when in contact with an aqueous environment (Coenye et al. 2011; Chen et 
al. 2013; Lo et al. 2014; Zanini et al. 2015). Such approaches are those most used to 
obtain devices with different antimicrobial spectra and duration. Indeed, a number of 
materials with entrapped antibiotics and disinfectants are commercially available, and 
are already used in clinical applications, especially for mitigating implant-associated 
infections (Antoci et al. 2008; Hockenhull et al. 2009; Francolini and Donelli 2010; 
Swartjes et al. 2015; Ashbaugh et al. 2016). Examples of active polymers for 
antimicrobial applications are reported in Gao et al. (2011), Chen et al. (2013) and 
Huang et al. (2016). 
Release of antibiotics by coating degradation is also possible by using 
degradable polymers, such as poly(D,L-lactide),  poly(ε-caprolactone) or 
poly(trimethylene carbonate) (Strobel et al. 2011; Guillaume et al. 2012). Shukla et al. 
(2012) found that application of vancomycin containing layer-by-layer assembled films 
increased drug loading by up to approximately 9 times the control. It is interesting to 
note that the approach enables the incorporation of different drug types in each layer, 
giving potential to engineered delivery system for drugs with a multitude release profile 
(Hammond 2012). 
However, despite the considerable effort made, over the past 30 years there has 
been little progress, few products have become available on the market, and reviews are 
not unanimous about their benefits (Johonson et al. 2006; Nowatzky et al. 2012; 
Sjollema et al. 2018). The prerequisite for the good performance of such coatings is the 
continuous and constant elution of antimicrobial molecules from the surface, with a 
release rate sufficient to deter or slow down microbial attachment to ensure the long 
service life of the coating (Barrios et al. 2005). Unfortunately, such active coatings have 
been designed to release high initial fluxes of antimicrobial agents during the critical 
short term post-implantation period (several hours) so as to inhibit initial microbial 
adhesion through a biocidal mechanism. However, continued release beyond this short-
term period (weeks to months) is not realized, making these systems less desirable for 
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long-term and extended applications (Hetrick and Schoenfisch 2006; Knetsch and 
Koole 2011; Gao et al. 2011).  
 
Antimicrobial responsive surfaces 
Several materials from which the antimicrobial substance release is triggered by 
the microorganisms approaching the surface have been proposed. Indeed, in such 
responsive approaches, both enzymes and acids excreted by the bacteria themselves 
have been used as triggers for antimicrobial release to combat their adhesion. 
Komnatnyy et al. (2014) introduced an enzyme-sensitive link into a poly(ethylene 
glycol) material. The bioactive compounds, i.e. quorum sensing signals and 
antimicrobial drugs, were only released in presence of the microorganisms that secrete 
the specific enzymes that cleave the sensitive linkage in the construction. Pavlukhina et 
al. (2014) constructed a pH/bacteria-responsive material providing a novel hydrogel-
like montmorillonite/polyacrylic acid film able to keep gentamicin safely sequestered 
for months under physiologic conditions. When challenged with bacteria, the coating 
released gentamicin because microorganisms locally acidify the environment, e.g. by 
secreting lactic or acetic acid. Similarly, Wang et al. (2017) developed a new multilayer 
film with a high loading capacity for triclosan. In this system, the permeability of the 
films is altered in response to pH changes in the environment caused by bacteria 
providing the release of the antibiotic. 
These responsive materials are supposed to provide new antimicrobial 
approaches with the following advantages: i) they exhibit the antibacterial activity only 
when and where needed; ii) they extend the useful life time of coatings, decreasing the 
premature depletion of the drug reservoir; and iii) they minimize side-effects related to 
continuous and uncontrolled molecule release, e.g. its accumulation in vital tissues. 
Though these materials are interesting, they are seldom used as antibacterial 
coatings. The main challenges are: i) to achieve release of meaningful doses over 
multiple cycles; ii) to minimize non-triggered background leaching from surfaces; iii) 
the limited effect against multiple microbial infections; and iv) the altered efficacy of 
many antimicrobials due to changes in pH during microbial growth (Cloutier et al. 
2015; Alvarez-Lorenzo et al. 2016).  
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Immobilization of antimicrobials  
Important achievements have also been made to covalently immobilize 
antimicrobials on surfaces to completely overcome the problem of constant release 
(Antoci et al. 2008; Gharbi et al. 2015; Gerits et al. 2016; Peng et al. 2017). These so-
called contact-killing surfaces are not intended to release antimicrobials into the 
surroundings, but to kill bacteria upon contact.  
The active molecule, covalently bound to the polymeric chain, reaches the site 
of action on the bacterial envelope or inside the bacterium, e.g. by penetrating its cell 
wall. Therefore, the bond with the surface is generally performed by using flexible 
spacers that allow a certain degree of freedom of the bound antibacterial agents (Nie et 
al. 2016). Indeed, chain length and chain density are important parameters for polymer 
brush anchors (Adhart et al. 2018). Jose et al. (2005) used a double 
aminoethoxyethoxyacetate linker combined with a 3-aminopropyltriethoxysilane-
modified titanium surface to provide vancomycin with a distance of about 4 nm from 
the polymer surface. 
In contrast to the release coatings, surface binding technology of antibiotic 
agents creates a high local concentration, minimizing the risk of exposing bacteria to 
sub-inhibitory concentrations and thereby reducing the likelihood of resistance 
development (Nie et al. 2016). Little is known about the possible development of 
bacterial resistance against these materials and it remains to be seen whether or not this 
occurs upon their increasing usage. Certainly, it has been well documented that the 
constant use of antimicrobial agents inevitably leads to the development of antibiotic 
resistant strains and could even promote biofilm formation (Hoffman et al. 2005; 
Andersson and Hughes 2010). Moreover, the effectiveness of such material is most 
likely limited to infections caused by bacteria that are sensitive to the specific antibiotic 
(Hetrick and Schoenfisch 2006). No less important: the application of such surface-
active systems is restricted to some surfaces for safety reasons, e.g. their use is less 
suitable for specific food contact materials as the carrying over of antimicrobials into 
food products might occur (Simões et al. 2010; Lucera et al. 2012; Cappitelli et al. 
2014). 
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Metal-based antimicrobial materials 
 
Metal coatings 
Heavy metals have been used as an anti-biofilm agent, the metal being deposited 
on biomaterial surfaces by means of a coating technology (Stobie et al. 2008; Gallo et 
al. 2014).  
Among the metals, the one that has long been the center of attention is silver 
(Knetsch and Koole 2011). There are indications that the antimicrobial activity of silver 
is dependent on the silver cation Ag+, which reacts with, and disrupts, the function of 
bacterial cell membranes, DNA molecules, crucial metabolic proteins and enzymes, and 
ultimately leads to cell death (Feng et al. 2000; Jung et al. 2008; Randall et al. 2013). 
Indeed, silver has been coated onto medical implants (Darouiche 1999; Devasconcellos 
et al. 2012), wound dressings (Heggers et al. 2005; Ip et al. 2006) and textiles (Sataev et 
al. 2014). However, such silver coating has its faults, including poor silver adhesion and 
lack of coating uniformity; it also requires special processing conditions (Kumar and 
Munstedt 2005). Furthermore, the incorporation of silver into polymers does not always 
result in efficient antimicrobial activity because of the poor solubility of most silver 
salts in polymeric materials (Knetsch and Koole 2011). 
 
Metal-nanoparticles based materials 
Over the last decade a great deal of interest has been shown in metal 
nanoparticles. This is because of the superior and unique features that make them 
particularly attractive for new and emerging nanoparticle-based anti-biofilm materials 
(Polo et al. 2011; Ahire et al. 2016; Mu et al. 2016; Qayyum and Khan 2016; 
Ramasamy and Lee 2016; Gambino et al. 2017). Among others, silver nanoparticle-
based materials have been successfully proposed to limit biofilm formation on both 
medical and industrial applications, e.g. medical implants (Roe et al. 2008), air and 
water treatment filters (Mpenyana-Monyatsi et al. 2012; Gehrke et al. 2015), clothing 
(Zhang et al. 2009; Zhang et al. 2014), food processing surfaces (Araujo et al. 2013) and 
food packaging materials (Bumbudsanpharoke et al. 2015; Souza and Fernando 2016). 
Although it seems that bacteria are less prone to develop resistance against silver than 
they do against conventional antibiotics, concerns associated with the overuse of silver 
and the consequent emergence of bacterial resistance have been raised (Hobman and 
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Crossman 2015; Ebrahiminezhad et al. 2016). Moreover, these nanotechnology-based 
emerging novel anti-biofilm strategies are still in the nascent phase and more research is 
needed to clarify a number of safety, environmental, ethical, policy and regulatory 
issues (Fabrega et al. 2011; Gottschalk et al. 2013; Sajid et al. 2015; Gambino et al. 
2015; Reed et al. 2016; Garuglieri et al. 2016; Hoseinnejad et al. 2017; Garuglieri et al. 
2018). 
 
Preventive green biocide-free surfaces 
Numerous concerns have put pressure on the scientific community to develop 
alternative, more effective strategies; strategies perceived by the public as safe, and as 
posing negligible risk to human health and the environment.  
Indeed, efforts are being directed towards developing innovative anti-biofilm 
materials with functional features targeting molecular determinants of biofilm genesis, 
instead of fighting biofilm with antimicrobial materials and coatings (Chen et al. 2013; 
Villa et al. 2013). In these approaches microorganisms are deprived of their virulent 
properties but their existence remains unaffected. Thus, selection pressure decreases, 
with the promising perspective of restoring the efficacy of traditional antimicrobial 
agents (Rasko and Sperandio 2010). 
On considering the process of biofilm formation, different key steps can be 
identified as promising targets for the development of innovative anti-biofilm products. 
The first is to avoid surface microbial adhesion: this can be done by interacting with the 
surface sensing process in order to keep the pioneering cells in a planktonic form. 
Another good point of attack that has emerged is the disruption of mature biofilm. 
Indeed, interference with cell-to-cell communication processes inevitably results in 
biofilm matrix damage, leading to the destabilization of biofilm physical integrity. 
Finally, the promotion of biofilm dispersal by forcing the planktonic state is another 
interesting target (Kaplan 2010; Kostakioti et al. 2013).  
Needless to say, the above strategies do not presume to be the solution to 
preventing biofilm development, but they could be used in combination with other 
conventional treatments to maximize the anti-biofilm performance of polymeric 
materials. Indeed, these strategies could be a step forward in applications where it 
would be advantageous to slow down contamination. Indeed, in many industrial and 
clinical activities, surface treatments that retard adhesion, and consequently biofilm 
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formation, could greatly enhance the efficiency of daily cleaning and disinfection 
procedures, because, once dispersed from the biofilm, free-floating microbes are more 
susceptible to detergents and biocides than those in the biofilm itself (Davey and 
O'Toole 2000; Dell’Orto et al. 2017). The synergic combination of antimicrobial and 
anti-biofilm agents is even recommended by the Infectious Diseases Society of America 
guidelines for the treatment of selected biofilm-associated infection (Pappas et al. 2004; 
Cui et al. 2015). 
Already, to date, a number of natural and synthetic compounds based on this 
innovative biocide-free anti-biofilm strategy have been proposed. The latter includes a 
broad range of molecules, free in solution as well as coated or immobilized on a surface, 
that interfere with quorum sensing cell-to-cell communications and promote biofilm 
dispersal (Ding et al. 2011; Wu et al. 2015; Alexander et al. 2015; Brackman and 
Coenye 2015; Abraham 2016; Chen et al. 2016), as well as matrix-targeting enzymes 
able to effectively destroy biofilm architecture (Pavlukhina et al. 2012; Villa et al. 2015; 
Spadoni Andreani et al. 2016; Sadekuzzaman et al. 2015; Meireles et al. 2016; Spadoni 
Andreani et al. 2017; Snarr et al. 2017). 
 
Surface modification with natural anti-biofilm compounds 
Present day awareness of ecological problems, together with the increased 
number of safety laws, has prompted the scientific community to address the 
development of more eco-sustainable anti-biofilm materials with non-toxic and 
biodegradable properties. Thus, there is great demand for new approaches based on 
molecules displaying suitable environmental-fate parameters such as high water 
solubility, low partition coefficient, low bioaccumulation in biological systems, and no 
ecotoxicity; such molecules used in anti-biofilm materials would give them great 
potential as safe anti-biofilm agents (Qian et al. 2010). To date, a multitude of 
compounds found in nature have revealed promising anti-biofilm properties suitable for 
the development of improved effective eco-friendly, bio-inspired anti-biofilm materials 
able to replace, or integrate with, current dominating biocide-based strategies (Villa et 
al. 2013; Sadekuzzaman et al. 2015; Qian et al. 2015; Almeida et al. 2017). However, 
compared to the great amount of work devoted to the discovery of potent natural 
biofilm inhibitors, relatively little research has dealt with the design of anti-infective 
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bio-hybrid surfaces based on natural products and, of these, only a few materials display 
anti-biofilm properties without biocidal activity. 
 
Passive and active natural molecule-based strategies 
Barrios and coauthors (2005) and Newby and colleagues (2006) incorporated 
zosteric acid into silicone coatings, developing different strategies to achieve its slow 
release into the surrounding area. Bryers and collaborators (2006) and Rosenberg and 
colleagues (2008) proposed salicylic acid-releasing poly(anhydride-ester) polymers able 
to inhibit Pseudomonas aeruginosa and Salmonella enterica biofilms respectively. In a 
further study, Nowatsky and coauthors (2012) developed a new salicylic acid-releasing 
polyurethane acrylate polymer. Under aqueous environments, the polymer hydrolyzed 
and released salicylic acid, leaving the backbone intact and reducing biofilm formation 
of Staphylococcus epidermidis, Bacillus subtilis, Escherichia coli, P. aeruginosa, and S. 
aureus. Others examples are reported in Table 2.  
Unfortunately, in most cases, these materials exhibited a discontinuous release, 
this release being initially high but soon followed by an exponential decrease. In 
addition, a very large number of molecules appeared close to the surface, reaching 
concentrations lethal for the microorganisms. The amount of released substance and its 
rate is influenced by factors like processing parameters, loading dose, applied 
technique, molecular size of the molecule and the physic-chemical properties of the 
polymeric material, all of which makes it arduous to carry out a strict monitoring of the 
anti-biofilm rate from the surface. Indeed, the problem of release rate in an aqueous 
medium can be attributed to the fact that most polymeric matrices and anti-biofilm 
compounds have incompatible physical characteristics. Most of the coating matrices are 
hydrophobic polymers, while some anti-biofilm compounds are hydrophilic, making 
their miscibility with the coating matrices difficult. The result is a non-uniform 
molecule distribution within the material, which increases the tendency of the surfaces 
to absorb and diffuse water through the polymer matrix; this allows the anti-biofilm 
molecules to diffuse out (Barrios et al. 2005; Newby et al. 2006; Nowatzki et al. 2012). 
To solve the problem, Barrios and coauthors (2005) investigated various techniques for 
incorporating zosteric acid into a model silicone material. When the zosteric acid 
distribution within the polymer was uniform, with small aggregates or even individual 
molecules, leaching took place at a reasonable rate, extending the material working 
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time. However, the optimal, and desired, constant rate was never reached as, at the 
beginning, the rate was quite high, reaching an almost constant value only later.  
 
Covalent immobilization of natural molecules 
The binding of natural molecules to surfaces could easily side-step the problem 
of constant release, guaranteeing the material long life as the molecules become 
permanently attached and integrated into the scaffold structure of the polymers. Indeed, 
grafting active compounds to polymers is preferred to covalent incorporation as biofilm 
development is a process that occurs at the surface and not in the bulk. This kind of 
approach requires very good knowledge of the exact functional groups required by 
molecules to exert anti-biofilm activity, identifying the molecular structure’s binding 
site needed for the group’s immobilization on the surface, without destroying the 
biological activity of the material. However, in most cases this information is not 
available.  Hume et al. (2004) proposed two different methods for the covalent 
immobilization of the furanone 3-(1’-bromohexyl)-5-dibromomethylene-2(5H) on 
biomaterials: a furanone co-polymerization with a styrene polymer and a plasma-1-
ethyl-3-(dimethylaminopropyl) carbodiimide reaction to produce furanone-grafted 
catheters. Biofilm formation by S. epidermidis in vitro was inhibited by 80% whereas in 
an in vivo sheep model immobilized furanones were found effective at controlling 
infection for up to 65 days. A study by Cattò et al. (2015) concerning the relationship 
between zosteric acid structure and anti-biofilm activity clarified that the carboxylic 
acid moiety conjugated to the double bond in trans configuration is necessary in the 
molecule to guarantee good anti-biofilm performance, while deletion of the sulphate 
ester group does not compromise molecule anti-biofilm activity. In addition, Cattò et al. 
(2017) showed that the para-position of the phenyl ring in the salicylic acid structure 
proved suitable for its immobilization on a N-hydroxysuccinimide polymeric matrix. On 
the basis of these two studies, Dell’Orto et al. (2017) covalently grafted modified 
cinnamic and salicylic acid on a low density polyethylene surface, previously activated 
by oxygen plasma treatment and using 2-hydroxymethylmetacrylate as linker. Both 
functionalized polymers displayed optimal anti-biofilm performance against E. coli, 
reducing biofilm surface coverage, thickness and cellular biovolume by more than 80%. 
Cattò et al. (2018) later confirmed that the reduction of biofilm biomass was achieved in 
both functionalized surfaces by a mechanism that did not affect bacterial viability, 
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which is an important factor in the challenge to limit the risk of developing resistant 
microbial strains. Additionally, the authors demonstrated that the functionalized 
surfaces strongly reduced polysaccharides in the biofilm matrix, maximizing the biofilm 
sensitivity to conventional antimicrobial agents. Noteworthy, the new polymers 
preserved their anti-biofilm activity over time.  
Although anti-biofilm mechanisms are still poorly understood, current findings 
document that, in most cases, anti-biofilm materials affect microbial settlement by 
acting as an environmental cue that leads bacteria to global stress, providing conditions 
by which the best microbial strategy is to escape from the adverse environment rather 
than activate drug resistant sessile mechanisms. This response is often mediated by 
reactive oxygen species, used by cells as signals in adapting to changing environments 
(Gambino and Cappitelli 2016). For example, both zosteric acid and salicylic acid affect 
the bacterial oxidative balance by interacting with NADH: quinone reductase (WrbA), 
an enzyme belonging to a family of flavoprotein quinone reductases widespread in both 
bacteria and fungi (Cattò et al. 2015; Cattò et al. 2017). The outcome of this oxidative 
imbalance is the production of signal molecules that discourage the firm adhesion of 
bacteria on surfaces (Villa et al. 2012; Cattò et al. 2015). 
 
Methods for evaluating the anti-biofilm performance of new bio-inspired 
polymeric surfaces 
After the design and creation of bio-inspired polymeric surfaces, the validation 
of the new materials’ anti-biofilm performance becomes a critical step for field 
applications. However, the in vivo testing of new anti-biofilm materials remains a 
difficult task due to the poor control over experiments and justified ethical concerns 
(Sjollema et al. 2018). Therefore, simplified in vitro systems have been developed to 
mimic different conditions encountered in vivo (Gomes et al. 2017).  
While a number of industrial standard tests are available to assess the 
antimicrobial efficacy of medical and non-medical products, no accepted standard 
methods exist to properly evaluate the anti-biofilm activity of new surfaces with a 
mechanism of action that is different from simple killing or growth inhibition. Indeed, 
available surface evaluation standard tests are mostly intended to assess the efficacy of 
surface by testing the material ability to decrease microbial viability without 
considering differences in the mechanism of action (Sjollema et al. 2018). Therefore, 
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the only way to test is by adapting the standard lab-scale devices and procedures to 
reproduce the biofilms on the functionalized biocide-free materials. 
 
Lab-scale systems for growing biofilms on anti-biofilm surfaces 
The simplest experimental system relies on the use of microtiter well plates, a 
static assay particularly useful for examining early events in biofilm formation (Merritt 
et al. 2005). Microtiter plates allow surfaces to be modified or, alternatively, new bio-
functionalized polymers can be further inserted into the wells. The general protocol 
allows for the inoculation of microtiter wells with a cell suspension for a desired period 
of time, after which the attached biomass is analyzed.  
While microtiter tray based techniques are inexpensive and appropriate for large 
scale screening purposes, the static nature of these systems leaves them prone to 
nutrient exhaustion, thus limiting the generation of mature biofilm (Azeredo et al. 
2017). As a consequence, the full effect of new tested materials on biofilm growth and 
dispersion cannot be evaluated with this system. 
The dynamic solution lies in continuous-flow systems to produce mature 
biofilms on surfaces. Indeed, continuously pumping high shear and nutrients into the 
reactor provides stress conditions that promote biofilm development on the polymer 
surfaces (Goeres et al. 2005). Standardized protocols employing the Center for Disease 
Control biofilm reactor (CDC reactor), the rotating disk reactor (RD reactor) and the 
drip flow reactor (DF reactor), have been approved by the American Society for Testing 
and Materials (ASTM E2562-12 2012; ASTM E2196-02 2012; ASTM E2871-13 2013; 
ASTM E2647-13 2013).  
The CDC reactor allowed Cai et al. (2012) to prove that diazeniumdiolate-doped 
poly(lactic-co-glycolic acid)-based nitric oxide releasing films applied in indwelling 
biomedical devices exhibit considerable anti-biofilm properties against gram-positive S. 
aureus and gram-negative E. coli. In another experiment, the CDC reactor was used to 
challenge dentin-composite and hydroxyapatite disks with multi-species oral biofilms, 
mimicking acidogenic meals and snacks (Li et al. 2014). Dell’Orto and colleagues 
(2017) tested a new anti-biofilm material obtained by the covalent grafting of p-
aminocinnamic or p-aminosalicylic acids on low density polyethylene coupons against 
E. coli biofilm grown in the CDC reactor. Sawant and colleagues (2013) tested the anti-
biofilm properties of silver nanocomposites against E. coli biofilm by the use of a DF 
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reactor. With the same device, Pérez-Díaz et al. (2016) evaluated the anti-biofilm 
capacity of chitosan gel formulations loaded with silver nanoparticles on strains of 
clinical isolates under conditions that mimic the flow of nutrients in the human skin.  
All the described continuous-flow systems offer the advantages of the 
simultaneous use of different surface materials, the possibility of analyzing samples 
noninvasively, and standardized protocols, making it possible to compare different 
materials within one laboratory alone and among different laboratories (Gomes et al. 
2017). Additionally, bioreactors allow to sample the materials aseptically at different 
time points during the sessile growth, without compromising the whole experiment.  
 
Methods for quantification and structural assessment of biofilm on anti-biofilm 
surfaces 
Once grown on a surface, the most widely used technique to estimate biofilm is 
the determination of viable cells by plate counting on agar media (Azeredo et al. 2017). 
Alternatively, flow cytometry, is a fast and precise way to count live and dead cells in a 
biofilm (Kerstens et al. 2015; Sgier et al. 2016). Quantification can be also achieved 
through colorimetric methods by staining biofilms and measuring the amount of 
desorbed dye by spectrophotometric measurement (Honraet et al. 2005; Welch et al. 
2012; Larimer et al. 2016; Sabatini et al. 2018). Depending on the stain, this method 
enables quantification of the total biofilm biomass (e.g., crystal violet), the biofilm 
matrix (e.g. dimethyl methylene blue), or the metabolic activity of the biofilm cells (e.g. 
XTT 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner 
salt and resazurin). Furthermore, quantitative polymerase chain reaction (qPCR) could 
be used to account for the uncultivable portion of the biofilm microbial community 
(Dalwai et al. 2007). 
Microscopy is one of the most powerful tools to assess the biofilm architecture 
on material surfaces. In particular, confocal Laser Scanning Microscopy (CLSM) allows 
the representation of the 3D architecture of the biofilm, and the acquisition of 
quantitative structural parameters such as biofilm bio-volume, thickness and roughness 
(Bridier and Briandet 2014) (Figure 1).  
The amount of biomass retrieved on the surface is not the only indication of the anti-
biofilm properties of a new material. In fact, functionalized materials might act by 
destabilizing biofilm organization and its physical integrity, compromising its structure 
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rather than decreasing the biomass on a surface (Villa et al. 2015). This mode of action 
might render the biofilm more prone to detachment and/or more susceptible to 
traditional antimicrobial agents. By using micro-bead force spectroscopy, it is possible 
to quantify biofilm adhesion and viscoelasticity at the micro-meter scale (Lau et al. 
2009; Angeloni et al. 2016). Additionally, Atomic Force Microscopy was used to 
determine the adhesion forces between bacteria and goethite (Huang et al. 2015), and 
between biofilms and different plastics (vinyl chloride, silicone resin, Nylon 66, 
polycarbonate, polypropylene, polyethylene and polymethylmethacrylate) 
(Harapanahalli et al. 2015; Hirai et al. 2015).  
The susceptibility of biofilms grown on functionalized materials to traditional 
antimicrobials is an important aspect to consider. In this respect, CLSM has been shown 
to be a powerful tool to analyze antimicrobial actions by a time course (minutes-to-
hours scale) visualization of live and dead cells through the biofilm structure during a 
biocidal treatment (Rani et al. 2005; Daddi Oubekka et al. 2012; Singh et al. 2016). The 
general protocol consists in staining biofilm grown on the coupon with specific 
fluorochromes in order to detect live and dead cells (e.g. LIVE/DEAD BacLight 
bacterial viability kit) or enzymatic activities (e.g. esterase activity marker CalceinAM).  
The biofilm is then exposed to the antimicrobial treatment, and any changes over time 
in fluorescent intensity due to cell inactivation are recorded under CLSM (Figure 2 and 
Video S1).  
 
Concluding remarks 
The use of surfaces that prevent or limit microbial adhesion and biofilm 
formation by depriving microorganisms of their biofilm-specific traits, without affecting 
their existence, has been proved instrumental in combating surface-associated biofilm. 
The integration of such innovative strategies with conventional approaches also appear 
to be a good strategy as, once the biofilm is destabilized, microorganisms are more 
sensitive to biocide treatments. Now, the hard part is to translate these ideas into 
commercial reality: although the value of the previously described research is 
indisputable, it is equally true that a number of issues have yet to be solved.  In contrast 
to the currently used solvent-based approaches, the design and synthesis of such surface 
materials needs to be focused on chemical approaches based on solvent-free, non-toxic 
reactions, adhering to the principles of green chemistry (Sheldon, 2016). In addition, the 
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diffusion of a natural-based surface commercially requires large amounts of natural 
materials, as, unfortunately, not all compounds are suitable candidates for commercial 
total synthesis due to their structural complexity (Dias et al. 2012). Advances in chemo-
informatics have partially filled previous gaps: high throughput screening has shortened 
times whereas structure-activity studies have permitted a drastic reduction in the size 
and chirality of bioactive natural products. However, these approaches are often limited 
by the general lack of information concerning the mechanism of action, the cellular 
receptors and the active chemical scaffold of many bioactive natural products. This 
understanding is also necessary to achieve more efficient and better targeted anti-
biofilm surfaces (Chen and Qian 2017). 
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Table 
Table 1. Comparison of various anti-biofilm strategies presented in the paper. 
Anti-biofilm 
strategy 
Mechanism Advantages Disadvantages 
Surface modification 
1. Passive surfaces 
1.1 Surface chemistry 
modifications 
Anti-adhesive coatings 
to reduce the adhesion 
force between bacteria 
and the solid surface. 
- Simple and economic. - Difficulties in creating 
surface-bound thin films 
amenable to industrial 
scale processing;  
- Anti-biofilm properties 
quickly masked by 
bacteria-produced 
substances; 
- Surface erosion during 
application; 
- Less suitable for long-
term applications; 
- Less biocompatibility 
with living tissue; 
- Toxicity concerns. 
 
1.2 Surface 
topography 
modifications 
Modification of surface 
topography with micro- 
and nanoscale features 
that minimize bacterial 
attachment. 
- No recruitment of 
additional cells and 
biofilm buildup; 
- No resistance against 
nanofeatures. 
- Nano-structuring 
methods expensive and 
not available for large 
scale production; 
- Discordant results 
about the efficacy. 
 
2. Active antimicrobial surfaces 
2.1 Antimicrobial-
releasing surfaces 
Biocidal agent actively 
eluted from the surface 
by contact with an 
aqueous environment. 
- Incorporation of 
different drugs in 
separate sets of layers. 
- Not controlled elution 
of antimicrobials from 
the surface; 
- Less suitable for long-
term applications; 
- Resistance against 
antimicrobials. 
- Limited applications 
for safety reason. 
 
2.2 Antimicrobial-
responsive 
surfaces 
Antimicrobial release 
triggered by 
microorganisms when 
approaching the surface. 
- Antimicrobial activity 
only when and where 
needed; 
- Extended material life 
time by decreased 
premature depletion of 
drug reservoir; 
- Limited accumulation 
of antimicrobials in vital 
tissues. 
 
- Not controlled elution 
of antimicrobials over 
multiple cycles; 
- Non-triggered 
background leaching 
from the surface; 
-Limited effect against 
multiple microbial 
infections; 
-Altered environmental 
condition by bacteria 
affect the release of 
antimicrobials. 
- Resistance against 
antimicrobials. 
- Limited applications 
for safety reason. 
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2.3 Immobilization of 
antimicrobials 
Antimicrobials 
covalently immobilized 
on a surface. 
- No release of 
antimicrobials from the 
surface; 
-Minimized risk to 
expose bacteria to sub-
inhibitory 
concentrations; 
- Reduced likelihood of 
resistance development; 
-Long-term activity. 
 
- Efficacy only against 
specific microorganism; 
- Limited applications 
for safety reason. 
 
3. Metal-based antimicrobial materials 
3.1 Metal coatings Heavy metal with 
antimicrobial activity, 
deposited on the surface 
or incorporated into a 
polymeric material. 
-Broad spectrum of anti-
microbial activity. 
- Poor solubility of metal 
into polymeric materials; 
- Poor metal adhesion to 
the surface; 
- Lack of coating 
uniformity; 
- Resistance against 
metals. 
 
3.2 Metal-
nanoparticles 
based materials 
Metals with 
antimicrobial activity, 
grouped onto 
nanoparticles and then 
incorporated into a 
polymeric material or 
coated or immobilized 
on a surface. 
- Nanosized particles 
increase the 
antimicrobial potency 
 
- Nano-structuring 
methods expensive and 
not available for large 
scale production; 
- Safety, environmental, 
ethical, policy and 
regulatory issues; 
- Resistance against 
metals. 
 
Preventive green biocide-free surfaces 
1. Surface modification with natural anti-biofilm compounds 
1.1 Passive and active 
natural molecule-
based strategies 
Natural molecules with 
anti-biofilm activity 
coated on or 
incorporated into a 
polymeric material or 
eluted from a surface. 
-No biocidal activity; 
-No development of 
resistance; 
-Enhanced efficacy of 
cleaning and disinfection 
procedures; 
-No toxicity concerns. 
 
- Discontinuous release 
of the compounds; 
- Non-uniform molecule 
distribution within the 
material  
- Incompatible physical 
characteristics of anti-
biofilm compounds and 
most polymeric 
matrices; 
- Mechanisms of action 
poorly understood. 
 
1.2 Covalent 
immobilization of 
natural molecules 
Natural molecules with 
anti-biofilm activity 
grafted on a surface or 
covalently incorporated 
into the polymer. 
- No biocidal activity; 
- No release of 
compounds from the 
surface; 
-No development of 
resistance; 
- Long-term activity; 
-No toxicity concerns; 
-Enhanced efficacy of 
cleaning and disinfection 
procedures. 
- Knowledge of the 
molecule functional 
groups required to exert 
the anti-biofilm activity; 
- Mechanisms of action 
poorly understood. 
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Table 2. Relevant examples of polymeric surfaces modified with natural anti-biofilm compounds. 
 Coating agent Polymer Coating  
method 
Target  
microorganism 
Target 
mechanism 
Remarks Reference 
P
A
S
S
IV
E
 S
T
R
A
T
E
G
Y
 
B-type 
proanthocyanidins 
Permanox plastic 
slide 
Spin coating onto a 
Permanox slide 
Staphylococcus 
epidermidis, 
Staphylococcus 
aureus, 
Enterococcus 
faecalis 
Bacterial adhesion Treated biofilm composed by 
few cell clusters or single 
attached cells; compatibility 
with mammalian cells 
Trentin et al. 
2015 
Cinnamaldehyde, 
carvacrol 
Poly(lactic-co-
glycolic acid) 
Incorporation in the 
polymer mixture 
E. coli, S. aureus, 
Pseudomonas 
aeruginosa 
Bacterial adhesion Efficacy against E. coli and S. 
aureus biofilm 
Zodrow et 
al. 2012 
Clove essential oil; 
Eugenol 
poly(D,L-lactide-
coglycolide) 
Incorporation in the 
polymer mixture 
Escherichia coli 
O157:H7 and K-12  
Bacterial adhesion, 
Biofilm maturation 
Reduction of biofilm 
biomass, thickness, and 
substratum coverage by ≥ 
90% 
Kim et al. 
2016 
Dibromohemibasta-
din-1 
Poly(ε-caprolactone-
co-δ-valerolactone) 
Varnish applied on 
the surface 
Paracoccus sp., 
Bacillus sp., 
Pseudoalteromonas 
sp. 
Bacterial adhesion, 
Biofilm maturation 
39.6% biofilm inhibition for 
Paracoccus sp.; no effect on 
Pseudolateromonas sp.  
and Bacillus 
Le Norcy et 
al. 2017 
Dihydrooroidin PVC plastic Mixed in a generic 
marine-based paint 
and applied on the 
surface 
Halomonas pacifica Bacterial adhesion Active after 3 weeks in a 
marine environment 
Melander et 
al. 2009 
N-
vanillylnonanamide 
 Polyurethane Dissolution in the 
polymer and  
sprayed on the 
surface 
Bacillus cereus, 
Bacillus 
thuringiensis, 
Pseudomanas 
stutzeri 
Bacterial adhesion No anti-adhesion effect Villa et al. 
2009 
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Rosmarinus 
officinalis essential 
oil 
Catheter 
pieces 
Functionalization on 
magnetite 
nanoparticles 
absorbed on the 
surface 
Candida albicans, 
Candida 
tropicalis 
Fungal adhesion, 
Biofilm maturation 
Important reduction in 
adhering cells 
and biofilm development 
Chifiriuc et 
al. 2012 
A
C
T
IV
E
 S
T
R
A
T
E
G
Y
 
Salicylic acid Poly(anhydride-
esters) 
Releasing of 
salicylic acid 
through the 
hydrolytic 
degradation of the 
polymer 
P. aeruginosa Bacterial adhesion, 
quorum sensing 
47% reduction of bacterial 
adhesion after 3 h; reduction 
of biofilm formation after 3 
days; resistant to cell 
degradation when implanted 
subcutaneously for 4 weeks  
Bryers et al. 
2006 
Salicylic acid Poly 
(anhydrideesters) 
Dispersion in the 
polimer 
Salmonella  enterica 
serovar 
Typhimurium 
Biofilm maturation No anti-biofilm effect at the 
air-liquid interface, no effect 
on cells attachment 
Rosenberg et 
al. 2008 
 
Salicylic acid Poly[1,6-bis(o-
carboxyphenoxy)-
hexanoate]  
Built into the 
polymer backbone  
Salmonella  
typhimurium  
MAE52 
Bacterial adhesion, 
Biofilm maturation 
Biofilm inhibition without 
affecting cells viability 
Guinta et al. 
2009 
 
Salicylic acid Polyurethane 
acrylate 
Co-polymerization 
with an acrylate-
bearing urethane 
resins 
E. coli, P. 
aeruginosa 
Biofilm maturation Reduction of biofilm 
formation for up to 5 days 
without affecting cells 
existence 
Nowatzki et 
al. 2012 
 
Zosteric acid Polystyrene poly[3-
hydroxyalkanoate-
co-3 -
hydroxyalkenaote] 
Dispersion and 
loading in 
polystyrene 
microcapsules   
Activated sludge Bacterial adhesion Efficacy only in the first 48 h 
of biofilm formation  
Geiger et al. 
2004 
Zosteric acid Polydimethylsilox- 
ane (Sylgard® 184) 
Incorporation in the 
polymer mixture  
Microbial 
consortium isolated 
from Lake Erie, 
Pseudomonas putida 
Bacterial adhesion 70% reduction of bacterial 
attachment 
Barrios et al. 
2005 
Zosteric acid  Sylicon Sylgard® 
184; Sylicon RTV11 
Incorporation in the 
polymer mixture  
Microbial 
consortium isolated 
from Lake Erie, P. 
putida 
Bacterial adhesion 75% reduction of bacterial 
attachment on Sylgard® 184 
and of 55% on RTV11  
Newby et al. 
2006 
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N
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A
C
H
M
E
N
T
 
Furanone 
3-(10-bromohexyl)5-
dibromomethylene-
2(5 H)- 
Polystyrene; Silastic 
Tenckhoff catheters 
Co-polymerisation 
with a styrene 
polymer; plasma-1-
ethyl-3-
(dimethylaminoprop
yl) carbodiimide 
reaction 
S. epidermidis Bacterial adhesion, 
Biofilm maturation 
Biofilm inhibited up to 89%; 
effective in vivo sheep model 
up to 65 days 
Hume et al. 
2004 
p-aminocinnamic 
acid;  
p-aminosalicylic 
acid 
Low-density 
polyethylene 
Covalent grafting on 
the surface 
E. coli Bacterial adhesion, 
Biofilm maturation 
Reduction of biofilm biomass 
up to 73 %; active after 
multiple use 
Dell’Orto et 
al. 2017 
p-aminocinnamic 
acid;  
p-aminosalicylic 
acid 
Low-density 
polyethylene 
Covalent grafting on 
the surface 
E. coli Bacterial adhesion, 
Biofilm maturation, 
Antimicrobial 
susceptibility 
Decreasing of biofilm 
thickness, roughness, 
substratum coverage, cell and 
matrix polysaccharide bio- 
volumes by > 80%; no 
biocidal activity; biofilm 
more susceptible to 
ampicillin and ethanol 
Cattò et al. 
2018 
Zosteric acid Poly[3-
hydroxyalkanoate-
co-3-
hydroxyalkenoate]  
Covalent 
incorporation in the 
polymer backbone  
Activated sludge Bacterial adhesion No cell attachment  
 
Hany et al. 
2004  
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Figures 
Figure 1. 3D-reconstructed CLSM images of E. coli biofilm grown on non-
functionalized (a) and functionalized with p-aminocinnamic acid (b) low density 
polyethylene surfaces. Biofilm grown on non-functionalized surface (a) shows a 
complex heterogeneous biofilm, with multi-layers of cells (green) organized in dense 
macro-colonies inside a well-structured polysaccharide matrix (red). On the contrary, 
biofilm grown on functionalized surface (b) shows a significant decrease in thickness 
with a uniform mono-layer of cells (green) and a significant reduction of polysaccharide 
matrix (red). Scale bar = 20 µm. © Cristina Cattò. 
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Figure 2. Time lapse CLSM of ethanol action performed on E. coli biofilm grown on 
non-functionalized (a) and functionalized with p-aminosalicylic acid (b) low density 
polyethylene surfaces. The fluorescence loss from stained E. coli cells is used to 
monitor real-time loss in cell viability during the biocide action. The images show that 
ethanol treatment did not affect green fluorescence of biofilm grown on the control 
surface within the 20 min of the experiment (a). On the contrary, ethanol treatment 
significantly affected the biofilm biomass integrity of biofilm grown on the 
functionalized surface, with a complete loss in fluorescent intensity in 5 min (b). Scale 
bar = 20 µm. © Cristina Cattò. 
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Supplemental material  
Video S1. Time lapse CLSM of ethanol action performed on E. coli biofilm grown on 
low density polyethylene surface functionalized with modified cinnamic acid. The 
technique permits the direct visualization of cell inactivation patterns in biofilm 
structures during the biocide action. The method is based on the monitoring of 
fluorescence loss from stained E. coli cells, used to monitor real-time loss in cell 
viability. © Cristina Cattò. 
 
 
 
 
 
 
 
 
 
 
 
